DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 84 filers reported holding DYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $215,865 | -21.7% | 24,092 | -1.7% | 0.00% | – |
| Q2 2023 | $275,799 | +123.7% | 24,500 | +128.9% | 0.00% | – |
| Q1 2023 | $123,310 | +2.1% | 10,704 | +2.7% | 0.00% | – |
| Q4 2022 | $120,791 | -9.2% | 10,422 | 0.0% | 0.00% | – |
| Q3 2022 | $133,000 | +51.1% | 10,422 | -18.3% | 0.00% | – |
| Q2 2022 | $88,000 | +14.3% | 12,757 | +59.9% | 0.00% | – |
| Q1 2022 | $77,000 | -18.9% | 7,978 | 0.0% | 0.00% | – |
| Q4 2021 | $95,000 | -26.4% | 7,978 | 0.0% | 0.00% | – |
| Q3 2021 | $129,000 | +81.7% | 7,978 | +134.6% | 0.00% | – |
| Q2 2021 | $71,000 | +163.0% | 3,401 | +98.2% | 0.00% | – |
| Q1 2021 | $27,000 | -12.9% | 1,716 | +16.2% | 0.00% | – |
| Q4 2020 | $31,000 | +210.0% | 1,477 | +198.4% | 0.00% | – |
| Q3 2020 | $10,000 | – | 495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $20,335,000 | 17.18% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $34,015,000 | 14.35% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $61,383,000 | 10.26% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,865 | $562,568,000 | 5.87% |
| Logos Global Management LP | 2,900,000 | $19,923,000 | 3.66% |
| Deep Track Capital, LP | 3,500,000 | $24,045,000 | 1.58% |
| HighVista Strategies LLC | 241,867 | $1,662,000 | 1.00% |
| Monashee Investment Management LLC | 319,536 | $2,195,000 | 0.80% |
| RA Capital Management | 2,805,045 | $19,271,000 | 0.51% |
| Vivo Capital, LLC | 577,642 | $3,968,000 | 0.40% |